Effects on Subclinical Heart Failure in Type 2 Diabetic Subjects on Liraglutide Treatment Versus Glimepiride Both in Combination With Metformin.
Phase of Trial: Phase II
Latest Information Update: 14 Sep 2016
At a glance
- Drugs Glimepiride (Primary) ; Liraglutide (Primary) ; Metformin (Primary)
- Indications Heart failure; Type 2 diabetes mellitus
- Focus Therapeutic Use
- 10 Jun 2017 Biomarkers information updated
- 31 Aug 2016 Status changed from recruiting to completed.
- 20 Jan 2016 Planned primary completion date changed from 1 Dec 2015 to 1 Mar 2016 as reported by ClinicalTrials.gov record.